Recent approaches in acute lymphoblastic leukemia in adults-Reference-Cited by-同舟云学术

Recent approaches in acute lymphoblastic leukemia in adults

Published:2000-10 Issue:1 Volume:36 Page:49-58
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Hoelzer Dieter,Gökbuget Nicola

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference53 articles.

1. Kantarjian HM, Walters RS, Keating MJ, et al. Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia. J Clin Oncol 1990;8:994–1004.

2. Improved results of an intensified therapy in adult acute lymphocytic leukemia;Lluesma-Gonalons;Ann. Oncol.,1991

3. The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by cancer and leukemia group B;Ellison;J. Clin. Oncol.,1991

4. Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB study;Cuttner;Leukemia,1991

5. Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report;Linker;Blood,1991

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minimal residual disease in acute leukemia based on the insight of molecular genetics monitoring;International Journal of ADVANCED AND APPLIED SCIENCES;2023-05

2. Chemotherapy-Free Targeted Anti-BCR-ABL+ Acute Lymphoblastic Leukemia Therapy May Benefit the Heart;Cancers;2022-02-15

3. Introduction;Chemotherapy and Pharmacology for Leukemia in Pregnancy;2020-09-27

4. Optimized induction of mitochondrial apoptosis for chemotherapy-free treatment of BCR-ABL+acute lymphoblastic leukemia;Leukemia;2018-12-13

5. High-dose chemotherapy and autologous peripheral blood stem cell transplantation with BCVAC regimen followed by maintenance chemotherapy for children with very high risk acute lymphoblastic leukemia;International Journal of Hematology;2017-10-20